Phana: a randomized double-blind two-arm phase II clinical trial was conducted for the study of safety and efficacy of Spikogen ®. This is a recombinant vaccine made by Cinnagen from SARS-Cov2 spike protein.

Chief researcher, Payam Tabarsi:

Three corona vaccines namely “CovIran Barekat”, “Razi Cov Pars”, and “Fakhra” have received the ethics code and have entered the clinical trial phase so far, all of which manufactured by the governmental company and institutes. Corona vaccine made by Cinnagen, one of the biggest manufacturers of biologic products in the Middle East, is the first in the country manufactured by a private company.